Knockdown of miR-484 and overexpression of CCL-18 both promoted the phosphorylation of PI3K and AKT in MGC-803 cell, suggesting that miR-484 exerts anti-cancer effects by targeting the CCL-18-PI3K/AKT pathway (35). This evidence concerns the gene AKT1 and cancer.